Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Lupus/Nephritis -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (17)	4/24/2001 2:06:18 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 95

Lupus warning signs. Since symptoms of lupus mimic other less serious illnesses, individuals often are fooled into dismissing these warning signs, yet all the while serious organ damage is occurring. The average patient waits three to five years before being properly diagnosed. Symptoms of lupus include: Achy, painful or swollen joints persisting for more than three months Unexplained fever over 100 degrees lasting more than a few days Persistent, extreme fatigue, exhaustion and weakness even after restful sleep Skin rashes, especially in the shape of a butterfly across the nose and cheeks Pain in the chest when breathing deeply

To: keokalani'nui who wrote (17)	4/24/2001 3:09:05 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 95

I performed DD for a major underwriter, 5/95. I recommended against a banking relationship. My confidentiality agreement is dated 5/3/95, and all obligations were limited to a period of five years. The proposed mechanism was induction of tolerance. Many, many observations have flowed by. There's been tons of spin and Abbott was, IMO, nuts. In 1995, I said "passive absorption, not tolerance". Now we're looking only at a subset of patients who have antibodies that react with the (IMO) adsorbent and at therapy with no "off" period. Hilarious. This is what happened to some old-time biotechs..... single-product companies, desperate to make it work...... quote.yahoo.com Again!! I urge everyone to look at old-time biotechs with a critical eye. Have they lost momentum and/or objectivity? Have they lost key personnel? Do they have access to critical expertise and "no people" (as opposed to "yes men") on a daily basis? I'm not saying that this subset of patients won't benefit from therapy. Wilder..... given your passion for the sector, you might profit from slowly digging through all of the posts to all three of the T/FIF threads. Just a thought.